Certa Therapeutics’ FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic…
Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, announces that the U.S. Food and Drug…
Read More...
Read More...